Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GUYOTAT D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Blaise, D; Maraninchi, D; Michallet, M; Reiffers, J; Jouet, JP; Milpied, N; Devergie, A; Attal, M; Sotto, JJ; Kuentz, M; Ifrah, N; Duriac, C; Bordigoni, P; Gratecos, N; Guilhot, F; Guyotat, D; Gluckman, E; Vernant, JP
      Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

      BLOOD
    2. Boudard, D; Sordet, O; Vasselon, C; Revol, V; Bertheas, MF; Freyssenet, D; Viallet, A; Piselli, S; Guyotat, D; Campos, L
      Expression and activity of caspases 1 and 3 in myelodysplastic syndromes

      LEUKEMIA
    3. Michallet, M; Thiebaut, A; Philip, I; Charrin, C; Vigouroux, C; Thomas, X; Bilger, K; Belhabri, A; Guyotat, D; Corront, B; Salles, B; Dumontet, C; Peaud, PY; Vilque, JP; Devidas, A; Fiere, D
      Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha

      LEUKEMIA
    4. Prudhomme-Lacroix, F; Jaubert, J; Mosnier, JF; Guyotat, D
      Hodgkin's disease of the tonsil: clinical, histological, immunophenotypical features and association with Epstein-Barr virus

      PRESSE MEDICALE
    5. Harousseau, JL; Witz, B; Lioure, B; Hunault-Berger, M; Desablens, B; Delain, M; Guilhot, F; Le Prise, PY; Abgrall, JF; Deconinck, E; Guyotat, D; Vilque, JP; Casassus, P; Tournilhac, O; Audhuy, B; Solary, E
      Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques

      JOURNAL OF CLINICAL ONCOLOGY
    6. Moukahal, MA; Jaubert, J; Guyotat, D
      Infectious complications in patients with common variable immunoglobulin deficiency. A retrospective case study.

      MEDECINE ET MALADIES INFECTIEUSES
    7. Michallet, M; Thomas, X; Vernant, JP; Kuentz, M; Socie, G; Esperou-Bourdeau, H; Milpied, N; Blaise, D; Rio, B; Reiffers, J; Jouet, JP; Cahn, JY; Bourhis, JH; Lioure, B; Leporrier, M; Sotto, JJ; Souillet, G; Sutton, L; Bordigoni, P; Dreyfus, F; Tilly, H; Gratecos, N; Attal, M; Leprise, PY; Demeocq, F; Michel, G; Buzyn, A; Delmas-Marsalet, B; Bernaudin, F; Ifrah, N; Sadoun, A; Guyotat, D; Cavazzana-Cavo, M; Caillot, D; De Revel, T; Vannier, JP; Baruchel, A; Fegueux, N; Tanguy, ML; Thiebaut, A; Belhabri, A; Archimbaud, E
      Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)

      BONE MARROW TRANSPLANTATION
    8. Michallet, M; Tanguy, ML; Socie, G; Thiebaut, A; Belhabri, A; Milpied, N; Reiffers, J; Kuentz, M; Cahn, JY; Blaise, D; Demeocq, F; Jouet, JP; Michallet, AS; Ifrah, N; Vilmer, E; Molina, L; Michel, G; Lioure, B; Cavazzana-Calvo, M; Pico, JL; Sadoun, A; Guyotat, D; Attal, M; Cure, H; Bordigoni, P; Sutton, L; Buzyn-Veil, A; Tilly, M; Leporrier, M; Fegueux, N; Dreyfus, F; Rio, B; Lutz, P; Vernant, JP
      Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

      BRITISH JOURNAL OF HAEMATOLOGY
    9. Campos, L; Sabido, O; Viallet, A; Vasselon, C; Guyotat, D
      Expression of apoptosis-controlling proteins in acute leukemia cells

      LEUKEMIA & LYMPHOMA
    10. Guyotat, D; Wahbi, K; Viallet, A; Piselli, S; Campos, L
      Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia

      LEUKEMIA
    11. Michallet, M; Perrin, MC; Belhabri, A; Molina, L; Nicolini, F; Tigaud, JD; Sotto, JJ; Guyotat, D; Fiere, D; Archimbaud, E
      Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    12. Tardy-Poncet, B; Tardy, B; Reynaud, J; Mahul, P; Mismetti, P; Mazet, E; Guyotat, D
      Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia

      CHEST
    13. Ifrah, N; Witz, F; Jouet, JP; Francois, S; Lamy, T; Linassier, C; Pignon, B; Berthou, C; Guyotat, D; Cahn, JY; Harousseau, JL
      Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia

      CANCER
    14. Misery, L; Cambazard, F; Rimokh, R; Ghohestani, R; Magaud, JP; Gaudillere, A; Perrot, JL; Berard, F; Claudy, A; Guyotat, D; Schmitt, D; Vincent, C
      Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: theanti-230-kDa autoantibody is not synthesized by leukaemic cells

      BRITISH JOURNAL OF DERMATOLOGY
    15. DACOSTA A; TARDYPONCET B; ISAAZ K; CERISIER A; MISMETTI P; SIMITSIDIS S; REYNAUD J; TARDY B; PIOT M; DECOUSUS H; GUYOTAT D
      PREVALENCE OF FACTOR-V-LEIDEN (APCR) AND OTHER INHERITED THROMBOPHILIAS IN YOUNG-PATIENTS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES

      HEART
    16. BRUNET I; PARET D; ORIOL P; GUYOTAT D
      THE COLLABORATION BOOKLET - A VEHICLE OF INFORMATION SERVING THE PATIENT

      Bone marrow transplantation
    17. MISERY L; GUYOTAT D; CAMBAZARD F
      LANGERHANS CELL HISTIOCYTOSIS AND ACUTE MONOCYTIC LEUKEMIA

      Annales de dermatologie et de venereologie
    18. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MAHE B; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; BUZYN A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; STAMATOULAS A; TILLY H; BRICE P; MALOISEL F; LIOURE B; DESABLENS B; PIGNON B; ABGRALL JP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    19. GUYOTAT D; WAHBI K; VIALLET A; PISELLI S; PRALAS J; CAMPOS L
      SELECTION OF PH-1-NEGATIVE STEM-CELLS FROM BLOOD OR MARROW OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA

      British Journal of Haematology
    20. CAMPOS L; BOUDARD D; SABIDO O; VIALLET A; PISELLI S; VASSELON C; GUYOTAT D
      IN-VITRO MODULATION OF CASPASE ACTIVITY IN MYELODYSPLASTIC SYNDROMES

      British Journal of Haematology
    21. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    22. GUILHOT F; MALOISEL F; GUERCI A; MICHALLET M; HAROUSSEAU JL; BRIERE J; ROCHANT H; CIURANA AJ; ABGRALL JF; GUYOTAT D; CHRISTIAN B; ORFEUVRE H
      UPDATE OF THE 810 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA-2B OR IFN ALPHA-2B AND CYTARABINE

      British Journal of Haematology
    23. WATTEL E; LELEU X; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGUEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      British Journal of Haematology
    24. PERRIN MC; JAUBERT J; REYNAUD J; MOUNIER C; ORIOL P; GUYOTAT D
      HIGH-INCIDENCE OF THROMBOTIC EVENTS IN MYELOMA PATIENTS

      British Journal of Haematology
    25. CAMPOS L; ORIOL P; SABIDO O; GUYOTAT D
      SIMULTANEOUS EXPRESSION OF P-GLYCOPROTEIN AND BCL-2 IN ACUTE MYELOID-LEUKEMIA BLAST CELLS

      Leukemia & lymphoma
    26. MAYNADIE M; CAMPOS L; MOSKOVTCHENKO P; SABIDO O; AHO S; LENORMAND B; CARLI PM; GUYOTAT D; BENE MC; FAURE G; CAPIOD JC; GARDAIS J; FEUILLARD J; RAPHAEL M; LACOMBE R; LECALVEZ G; LEGLISE MC; DENEYS V; MASSON AM; BERNIER M; MALET AM; SALAUN C; BOURIN P; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; MOSKOVTCHENKO P; FAVRE M; BENSA JC; JACOB MC; WALLEF G; SARIAUX C; TRIMOREAU F; PRALORAN V; CAMPOS L; SABIDO O; VASSELON C; BRUNET C; PONCELET P; GUITARD AM; TAIB J; LAVABREBERTRAND T; JUNG G; KANDEL G; GARAND R; PHILIP P; SUDAKA I; MONPOUX F; VANHAEKE D; PERROT JY; MARIE JP; VALENSI F; VERGE V; HOMBERG JC; SCHAISON G; BOUMSELL L; DOUAY L; SAMSON T; BRIZARD A; DALIPHARD S; DRENOU B; LEES O; LENORMAND B; POILANE B; FALKENRODT A; ALBERT A; KUHLEIN E; ESTIENNE MH; BREMOND JL; DEGENNE M; LEBARON F; REUMAUX G; DUTHILLEUL P; BENE MC; FAURE G; BORDIGONI P; WITZ F; KOLLOPSARDA MN; BAYLE C; ANTONINI J; BOUCHEIX C; CHARPENTIER A
      HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS

      Leukemia & lymphoma
    27. DACOSTA A; TARDYPONCET B; ISAAZ K; CERISIER A; MISMETTI P; SIMITSIDIS S; RAYNAUD J; TARDY B; DECOUSUS H; GUYOTAT D
      PREVALENCE OF FACTOR-V-LEIDEN AND OF OTHER INHERITED THROMBOPHILIA INYOUNG-PATIENTS UNDER 45 YEARS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES - A PROSPECTIVE-STUDY

      Thrombosis and haemostasis
    28. DACOSTA A; TARDYPONCET B; ISAAZ K; CERISIER A; MISMETTI P; SIMITSIDIS S; REYNAUD J; BACHONGY P; DECOUSUS H; GUYOTAT D
      FACTOR-V-LEIDEN AND ACUTE MYOCARDIAL-INFARCTION WITH NORMAL CORONARY-ARTERIES - A CASE-CONTROL STUDY

      Thrombosis and haemostasis
    29. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; IFRAH N; ABGRALL JP; GUYOTAT D; DUPRIEZ B; PENY AM; BRICE P; PIGNON B; LEPORRIER M; LEPELLEY P; FENAUX P
      INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)

      Experimental hematology
    30. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      Experimental hematology
    31. GUILHOT F; GUERCI A; MALOISEL F; MICHALLET M; HAROUSSEAU JL; BOUABDALLAH R; GUYOTAT D; ABGRALL JF; IFRAH N; BRIERE J; TERTIAN G; BAUTERS F; NAVARRO M; MORICE P; CHRISTINA B; VILQUE JM; BLANC M; CHASTANG C
      RELATIONSHIP BETWEEN CYTOGENETIC RESPONSE AND SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA - RESULTS OF 2 MULTICENTRIC TRIALS

      Experimental hematology
    32. JOURDAN E; MARANINCHI D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; MOLINA L; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNEAU C; TILLY H; VILMER E; BARDOU VJ; BLAISE D
      EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA

      Bone marrow transplantation
    33. GUILHOT F; CHASTANG C; MICHALLET M; GUERCI A; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; CHERON N; NICOLINI F; ABGRALL JF; TANZER J
      INTERFERON ALFA-2B COMBINED WITH CYTARABINE VERSUS INTERFERON ALONE IN CHRONIC MYELOGENOUS LEUKEMIA

      The New England journal of medicine
    34. TARDY B; TARDYPONCET B; LAPORTESIMITSIDIS S; MISMETTI P; DECOUSUS H; GUYOTAT D; BERTRAND JC
      EVOLUTION OF BLOOD-COAGULATION AND FIBRINOLYSIS PARAMETERS AFTER ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN PATIENTS WITH VENOUS THROMBOEMBOLISM - A DOUBLE-BLIND RANDOMIZED STUDY

      British Journal of Haematology
    35. HAROUSSEAU JL; CAHN JY; PIGNON B; WITZ F; MILPIED N; DELAIN M; LIOURE B; LAMY T; DESABLENS B; GUILHOT F; CAILLOT D; ABGRALL JF; FRANCOIS S; BRIERE J; GUYOTAT D; CASASSUS P; AUDHUY B; TELLIER Z; HURTELOUP P; HERVE P
      COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA

      Blood
    36. LIOURE B; WITZ F; DECONNINCK E; DELAIN M; SOLARY E; BERTHOU C; AUDHUY B; FRANCOIS S; GUYOTAT D; SADDOUN A; PIGNON B; HAROUSSEAU JL; OBERLING F
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP

      Blood
    37. GUILHOT F; GUERCI A; MALOISEL F; HAROUSSEAU JL; BRIERE J; IFRAH N; ABGRALL JF; GUYOTAT D; CHRISTIAN B; BAUDUER F; JAUBERT D; MARTIN C; GUILHOT J; CHASTANG C
      FOLLOW-UP OF 1047 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, TREATEDWITH INTERFERON OR INTERFERON AND CYTARABINE

      Blood
    38. CAMPOS L; SABIDO O; VIALLET A; PISELLI S; GUYOTAT D
      IMPLICATION OF ICE AND CPP32 IN THE IN-VITRO GROWTH DEFECTS OF COMMITTED PROGENITORS FROM MYELODYSPLASTIC SYNDROMES

      Blood
    39. CAMPOS L; SABIDO O; SEBBAN C; CHARRIN C; BERTHEAS MF; FIERE D; GUYOTAT D
      EXPRESSION OF BCL-2 PROTOONCOGENE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia
    40. TARDYPONCET B; REYNAUD J; TARDY B; MAHUL P; MISMETTI P; BERAUD AM; REBAUD MA; BAYON M; GUYOTAT D
      ORG-10172 FOR HEPARIN-INDUCED THROMBOCYTO PENIA - TOLERANCE AND EFFICACY

      La Presse medicale
    41. GUILHOT F; GUERCI A; FIERE D; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; ROCHANT H; NAJMAN A; NICOLINI F; COLOMBAT P; ABGRALL JF; IFRAH N; BRIERE J; BAUTERS F; NAVARRO M; MORICE P; BORDESSOULE D; VILQUE JP; DESABLENS B; TERTIAN G; BLANC M; CHASTANG C; TANZER J
      THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY INTERFERON AND CYTOSINE-ARABINOSIDE - RATIONAL AND DESIGN OF THE FRENCH TRIALS

      Bone marrow transplantation
    42. TARDY B; TARDYPONCET B; BARA L; LAPORTESIMITSIDIS S; RASCLE F; SAMAMA MM; GUYOTAT D; BERTRAND JC
      EFFECTS OF LONG TRAVELS IN SITTING POSITION IN ELDERLY VOLUNTEERS ON BIOLOGICAL - MARKERS OF COAGULATION ACTIVATION AND FIBRINOLYSIS

      Thrombosis research
    43. PIGNON B; WITZ F; DESABLENS B; LEPRISE PY; FRANCOIS S; LINASSIER C; BERTHOU C; CAILLOT D; LIOURE B; CAHN JY; CASASSUS P; SADOUN A; AUDHUY B; GUYOTAT D; BRIERE J; VILQUE JP; BARANGER L; POLIN V; BERTHAUD P; HURTELOUP P; HERVE P; HAROUSSEAU JL
      TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE

      British Journal of Haematology
    44. CHARRIN C; MAGAUD JP; SEBBAN C; FIERE D; DASTUGUE N; HUGUETRIGAL F; ATTAL M; SIE P; LAI JL; JOUET JP; SIMON M; ZANDECKI M; GREGOIRE MJ; WITZ F; WITZ B; BARIN C; MORAINE C; MUGNERET F; FAVRE B; RAYNAUD S; GRATECOS N; THYSS A; AYRAUD N; LAFAGE M; AMOULET C; SAINTY D; MOZZICONACCI MJ; STOPPA AM; BERNARD P; REIFFERS J; BARANGER L; BOASSON M; IFRAH N; VANDENAKKER J; PERROT C; BERTHEAS MF; VASSELON C; CALMARD P; GUYOTAT D; TALMANT P; UETTWILLER F; MALOLSEL F; RUCH JV; OBERLING F; WEH HJ; VERELLENDUMOULIN C; LIBOUTON JM; DELANNOY A; FERRANT A; MICHAUX JL; DESANGLES F; RIVIERE D; PLUCHONRIVIERE E; BERTHOU C; PEDRON MF; NOEL B; LESPINASSE J; MECUCCI C; VANDENBERGHE H; BERGER R; POLSSONNIER M; NOEL L; GARDIN C; TURELURE P; VERHEST A; GIOLLANT M; DOSSANTOS E; TOUMILHAC O; RAMOND S; DREYFUS F; ZITTOUN R; SMADJA N; KRULIK M; SCHOENWALD M; VAUGLER GL; LEBLOND V; HURET JL; GIRAUD C; TANZER J; ECLACHE V; CAPODANO AM; ZATTARACANNONI H; LEONARD C; TCHERNIA G
      CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996)

      Blood
    45. SOLARY E; WITZ B; CAILLOT D; MOREAU P; DESABLENS B; CAHN JY; SADOUN A; PIGNON B; BERTHOU C; MALOISEL F; GUYOTAT D; CASASSUS P; IFRAH N; LAMY Y; AUDHUY B; COLOMBAT P; HAROUSSEAU JL
      COMBINATION OF QUININE AS A POTENTIAL REVERSING AGENT WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE LEUKEMIAS - A RANDOMIZED MULTICENTER STUDY

      Blood
    46. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET IP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      Blood
    47. GUILHOT F; CHASTANG C; GUERCI A; MICHALLET M; HAROUSSEAU JL; MALOISEL F; BRIERE J; BOUABDALLAH R; GUYOTAT D; TERTIAN G; NICOLINI F; ABGRALL JF; NAVARRO M; BLANC M; BRICE P; SIMON M; IFRAH N; ROCHANT F; VILQUE JP; DELAIN M; GUILHOT J; TANZER J
      INTERFERON ALPHA2B (IFN) AND CYTARABINE (ARA-C) SURVIVAL AND CYTOGENETIC RESPONSE IN CHRONIC LEUKEMIA (CML) - RESULTS OF A RANDOMIZED TRIAL

      Blood
    48. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; HOANGNGOC L; MALOSIEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; IFRAH N; ABGRALL IP; GUYOTAT D; DUPRIEZ B; PENY AM; BRICE P; PIGNON B; LEPORRIER M; LEPELLEY P; FENAUX P
      QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP)

      Blood
    49. GUYOTAT D; VIALLET A; SABIDO O; CAMPOS L
      EXPRESSION OF BCL-2-RELATED AND ICE-RELATED PROTEINS IN ACUTE MYELOIDLEUKEMIAS (AML) AND MYELODYSPLASTIC SYNDROMES (MDS)

      Blood
    50. CHARRIN C; MAGAUD JP; SEBBAN C; FIERE D; DASTUGUE N; HUGUETRIGAL F; ATTAL M; SIE P; LAI JL; JOUET JP; SIMON M; ZANDECKI M; GREGOIRE MJ; WITZ F; WITZ B; BARIN C; MORAINE C; MUGNERET F; FAVRE B; RAYNAUD S; BAUDOIN F; GRATECOS N; THYSS A; AYRAUD N; LAFAGE M; ARNOULET C; SAINTY D; MOZZICONACCI MJ; STOPPA AM; BERNARD P; REIFFERS J; VANDENAKKER J; PERROT C; BERTHEAS MF; VASSELON C; CALMARD P; GUYOTAT D; TALMANT P; UETTWILLER F; MALOISEL F; RUCH JV; OBERLING F; WEH HJ; VERELLENDUMOULIN C; LIBOUTON JM; DELANNOY A; FERRANT A; MICHAUX JL; DESANGLES F; RIVIERE D; PLUCHONRIVIERE E; BERTHOU C; PEDRON MF; NOEL B; LESPINASSE J; MECUCCI C; VANDENBERGHE H; BERGER R; POISSONNIER M; NOEL L; GARDIN C; TURELURE P; VERHEST A; GIOLLANT M; DOSSANTOS E; TOURNILHAC O; RAMOND S; DREYFUS F; ZITTOUN R; SMADJA N; KRULIK M; SCHOENWALD M; VAUGIER GL; LEBLOND V; HURET JL; GIRAUD C; TANZER J; ECLACHE V; CAPODANO AM; ZATTARACANNONI H; LEONARD C; TCHERNIA G
      CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE

      Blood
    51. CAMPOS L; GUYOTAT D
      EXPRESSION OF THY-1 ANTIGEN (CDW90) ON ADULT ACUTE-LEUKEMIA BLAST CELLS

      Blood
    52. MISERY L; GUYOTAT D; BOUCHERON S; CLAUDY A
      ARE NEUTROPHILIC DERMATOSES DURING GRANULOCYTOPENIA REALLY NEUTROPHILIC

      Archives of dermatology
    53. CAMPOS L; SABIDO O; VIALLET A; GUYOTAT D
      REACTIVITY OF CD34 MONOCLONAL-ANTIBODIES WITH HEMATOPOIETIC PROGENITORS AND ACUTE LEUKEMIAS

      Tissue antigens
    54. VANHAEKE DR; BENE MC; GARAND R; FAURE GC; GARDAIS J; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND T; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; VANHAEKE D; BERNARD A; VALENSI F; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; BRIZARD A; DALIPHARD S; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
      EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia & lymphoma
    55. FARREL V; SCHMITT T; STEPHAN JL; GUYOTAT D; PUEL G; CALMARDORIOL P; JAUBERT J; TALABARD JN; FREYCON F
      TOTAL-BODY IRRADIATION (TBI) BEFORE BONE-MARROW GRAFTING (BMG) - ANALYSIS OF LATE SIDE-EFFECTS

      European journal of cancer
    56. JOURDAN E; MARANINCHI D; REIFFERS J; ARCHIMBAUD E; MICHALLET M; HAROUSSEAU JL; IFRAH N; RIO B; GUYOTAT D; GUILHOT F; ATTAL M; LEBLOND V; DAURIAC C; LEGROS M; PICO JL; MARIT G; BLAISE D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION REMAINS AN EFFICIENT CONSOLIDATION FOR ADULTS WITH ACUTE MYELOID-LEUKEMIA EVEN WHEN PERFORMED VERY SOON AFTER DIAGNOSIS (LESS-THAN-100 DAYS)

      Leukemia
    57. COIGNET L; BERTHEAS MF; FRAPPAZ D; CALMARDORIOL P; JAUBERT J; VINDIMIAN M; BRIZARD CP; FREYCON F; GUYOTAT D
      FOLLOW-UP OF BONE-MARROW TRANSPLANTATION USING MINISATELLITE MS-31 AND MS-43 PROBES - COMPARISON WITH CHROMOSOMAL-POLYMORPHISM DATA

      La Presse medicale
    58. TARDY B; TARDYPONCET B; SIMITSIDIS S; DECOUSUS H; MISMETTI P; LEIZOROVICZ A; BERTRAND JC; GUYOTAT D
      ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN VENOUS THROMBOEMBOLIC DISEASE - A DOUBLE-BLIND RANDOMIZED STUDY

      Thrombosis and haemostasis
    59. TARDYPONCET B; REYNAUD J; TARDY B; MAHUL P; MISMETTI P; DECOUSUS H; GUYOTAT D
      EFFICACY AND SAFETY OF ORGARAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA

      Thrombosis and haemostasis
    60. CAMPOS L; ROUBI N; GUYOTAT D
      DEFINITION OF OPTIMAL CONDITIONS FOR COLLECTION AND CRYOPRESERVATION OF UMBILICAL-CORD HEMATOPOIETIC-CELLS

      Cryobiology
    61. TARDYPONCET B; MAHUL P; BERAUD AM; FAVRE JP; TARDY B; GUYOTAT D
      FAILURE OF ORGARAN THERAPY IN A PATIENT WITH A PREVIOUS HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME

      British Journal of Haematology
    62. MICHALLET M; MOULLET I; ARCHIMBAUD E; TARDY JC; DHEDIN N; BELHABRI A; GUYOTAT D; TIGAUD JD; AYMARD M; FIERE D
      RETROSPECTIVE STUDY OF HEPATITIS-C VIRUS-INFECTION IN 244 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANT (1980 TO 1993)

      Blood
    63. WITZ F; HAROUSSEAU JL; SADOUN A; GUYOTAT D; BERTHOU C; CAHN JY; GARDIN C; LIOURE B; WITZ B; DESABLENS B; IFRAH N; PIGNON B; LEPRISE PY; AUDHUY B; CAILLOT D; CASASSUS P; LINASSIER P; CHRISTIAN B; HURTELOUP P; POLIN V; TELLIER Z
      GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)

      Blood
    64. CAMPOS L; GUYOTAT D
      EXPRESSION OF THY-1 (CDW90) ON ADULT ACUTE-LEUKEMIA BLAST CELLS

      Blood
    65. GUYOTAT D; SEBBAN C; BERTHEAS MF; CHARRIN C; FIERE D; CAMPOS L
      SIGNIFICANCE OF BCL-2 PROTOONCOGENE EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS

      Blood
    66. SOLARY E; WITZ B; CAILLOT D; MOREAU P; DESABLENS B; CAHN JY; MALOISEL F; SADOUN A; PIGNON B; GUYOTAT D; CASASSUS P; IFRAH N; AUDHUY B; BERTHOU C; DELAIN M; LAMY T; HAROUSSEAU JL
      PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS

      Blood
    67. WATTEL P; SOLARY E; CAILLOT D; IFRAH N; BRIAN A; MAHE B; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE P; LIOURE B; DESABLENS E; PIGNON B; ABGRALL IP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; MERLAT A; FENAUX P
      INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL

      Blood
    68. DEVERGIE A; BLAISE D; ATTAL M; TIGAUD JD; JOUET JP; VERNANT JP; BORDIGONI P; IFRAH N; DAURIAC C; CAHN JY; LIOURE B; TROUSSARD X; REIFFERS J; GRATECOS N; MILPIED N; BELANGER C; GUYOTAT D; TILLY H; MICHALLET M; GLUCKMAN E
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE - A RANDOMIZED TRIAL OF BUSULFAN-CYTOXAN VERSUS CYTOXAN-TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN - A REPORT FROM THE FRENCH-SOCIETY-OF-BONE-MARROW-GRAFT (SFGM)

      Blood
    69. GARAND R; BENE MC; GARDAIS J; DUBOSCMARCHENAY N; LACOMBE F; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND TL; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; POMIER G; BERNARD A; REGUER M; SCHILL H; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; VANHAECKE D; BRIZARD A; ROUALET JP; TABARY T; CHAUMAREL I; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; LEPETIT JC; ACQUART S; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; ROUBINET F; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
      A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE

      Leukemia & lymphoma
    70. SHEN N; FFRENCH P; GUYOTAT D; FFRENCH M; FIERE D; BRYON PA; DECHAVANNE M
      EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      European journal of haematology
    71. ARCHIMBAUD E; THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D
      PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA

      Journal of clinical oncology
    72. SOLARY E; GENNE P; WITZ B; MILPIED N; CAHN JY; MALOISEL F; QUIQUANDON I; SADOUN A; IFRAH N; CASASSUS P; BERTHOUX P; AUDHUY B; PIGNON B; LAMY T; GUYOTAT D; COLOMBAT P; STOPPA AM; KUENTZ M; GUY H; HAROUSSEAU JL
      CLINICAL-TRIALS OF THERAPEUTIC MDR REVERS ION IN ACUTE LEUKEMIAS

      Pathologie et biologie
    73. TARDYPONCET B; TARDY B; GRELAC F; REYNAUD J; MISMETTI P; BERTRAND JC; GUYOTAT D
      PENTOSAN POLYSULFATE-INDUCED THROMBOCYTOPENIA AND THROMBOSIS

      American journal of hematology
    74. MISERY L; BLANC L; PERROT JL; BOUCHERON S; VASSELON C; GUYOTAT D; CLAUDY A
      SWEETS-SYNDROME OCCURRING DURING AGRANULO CYTOSIS - PHYSIOPATHOLOGICAL HYPOTHESIS

      Annales de dermatologie et de venereologie
    75. SOLARY E; WITZ F; MOREAU P; QUIQUANDON I; GENNE P; FLESCH M; SADDOUN A; MALOISEL F; PIGNON B; ABGRALL JF; GUYOTAT D; CASASSUS P; GARDEMBAS M; LAMY Y; AUDHUY B; LINASSIER C; CAILLOT D; HAROUSSEAU JL
      MITOXANTRONE-ARACYTINE WITH OR WITHOUT QU ININE IN THE TREATMENT OF ACUTE-LEUKEMIA, RESISTANT OR IN REMISSION

      Nouvelle revue francaise d'hematologie
    76. CAMPOS L; SABIDO O; ROUAULT JP; GUYOTAT D
      EFFECTS OF BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES ON IN-VITRO PROLIFERATION AND SURVIVAL OF NORMAL MARROW PROGENITORS AND LEUKEMIC-CELLS

      Blood
    77. WITZ F; HAROUSSEAU JL; CAHN JY; ABGRALL JF; BRIERE J; SADOUN A; GUYOTAT D; HURTELOUP P; MERCIER M; BERTHAUD P
      GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)

      Blood
    78. HAROUSSEAU JL; PIGNON B; WITZ F; LINASSIER P; LIOURE B; LEPRISE PY; CAHN JY; DESABLENS B; CAILLOT D; IFRAH N; ABGRALL JF; SADOUN A; GUYOTAT D; MORS A; CASASSUS P; BRIERE J; POLIN V; BERTHAUD P; HURTELOUP P
      PROSPECTIVE COMPARISON OF ALLOGENIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) AND UNPURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS POST REMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA (AML)

      Blood
    79. CAMPOS L; SABIDO O; GUYOTAT D
      IN-VITRO MODULATION OF BCL-2 AND P170 GLYCOPROTEIN EXPRESSION IN CD34-POSITIVE PROGENITOR CELLS BY HEMATOPOIETIC GROWTH-FACTORS

      Blood
    80. MICHALLET M; ARCHIMBAUD E; MOLINA L; PERRIN MC; BELHABRI A; GUYOTAT D; NICOLINI F; TIGAUD JD; HOLLARD D; FIERE D
      IMPACT OF GRAFT-VERSUS-HOST DISEASE PROPHYLACTIC AND THERAPEUTIC MANAGEMENT ON SURVIVAL AND DURATION OF COMPLETE REMISSION

      Blood
    81. BLAISE D; OLIVE D; ARCHIMBAUD E; REIFFERS J; LEBLOND V; MICHALLET M; VERNANT JP; IFRAH N; BELLANGER C; ATTAL M; MILPIED N; MARIT G; GUYOTAT D; CAUDRELIER P; HIRN M; MARANINCHI D
      GVHD PROPHYLAXIS WITH AN ANTI-IL2 RECEPTOR MONOCLONAL-ANTIBODY - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL IN STANDARD RISK LEUKEMIA

      Blood
    82. JOURDAN E; BLAISC D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNCAU C; TILLY H; VILMER E; MARANINCHI D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT WITH ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE

      Blood
    83. MISERY L; CAMPOS L; SABIDO O; KANITAKIS J; DEZUTTERDAMBUYANT C; GUYOTAT D; SCHMITT D
      S100 PROTEIN AND NEURON-SPECIFIC ENOLASE ON MONOCYTIC LEUKEMIC CD1+ CELLS, PROBABLE PRECURSORS OF LANGERHANS CELLS

      European journal of haematology
    84. TARDY B; TARDYPONCET B; REYNAUD J; LAPORTESIMITSIDIS S; BORDET JC; PAGE Y; DECOUSUS H; GUYOTAT D; BERTRAND JC
      EVOLUTION OF BIOLOGICAL MARKERS OF HEMOSTATIC ACTIVATION AFTER A LONGTRAVEL IN SITTING POSITION IN ELDER VOLUNTEERS

      Thrombosis and haemostasis
    85. TARDYPONCET B; REYNAUD J; RICHARD O; LAPORTESIMITSIDIS S; GOUNOT R; GUYOTAT D
      WHAT ARE THE NORMAL VALUES OF THE COAGULATION INHIBITORS IN CHILDREN

      Thrombosis and haemostasis
    86. SHEN N; FFRENCH P; VILLE D; GUYOTAT D; FFRENCH M; HANSS M; FIERE D; BRYON PA; DECHAVANNE M
      EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Thrombosis and haemostasis
    87. CALLET E; BERTHEAS MF; CAMPOS L; COIGNET L; CALMARDORIOL P; ROUBI N; VASSELON C; GUYOTAT D
      IDENTIFICATION OF CLONAL ORIGIN OF LEUKEMIC BONE-MARROW COLONIES IN ACUTE MYELOID-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS) USING FLUORESCENCE IN-SITU HYBRIDIZATION WITH SPECIFIC CHROMOSOME PROBES

      Experimental hematology
    88. SUTTON L; KUENTZ M; CORDONNIER C; BLAISE D; DEVERGIE A; GUYOTAT D; LEBLOND V; FLESCH M; BORDIGONI P; ATTAL M; REIFFERS J; IFRAH N; MILPIED N; GRATECOS N; CAILLOT D; TROUSSARD X; BELANGER C; FACON T; PICO JL; MICHALLET M; RIO B; LIOURE B; VERNANT JP
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - FACTORS PREDICTIVE OF TRANSPLANT-RELATED MORTALITY AND INFLUENCE OF TOTAL-BODY IRRADIATION MODALITIES

      Bone marrow transplantation
    89. COIGNET L; BERTHEAS MF; VASSELON C; JAUBERT J; REYNAUD J; CALMARDORIOL P; BRIZARD CP; GUYOTAT D
      TRISOMY-12 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - INTERPHASE STUDY BY INSITU HYBRIDIZATION IN 75 PATIENTS

      Nouvelle revue francaise d'hematologie
    90. TARDY B; TARDYPONCET B; PAGE Y; DECOUSUS H; GUYOTAT D; BERTRAND JC
      LOW-MOLECULAR-WEIGHT HEPARIN FOR HICKMAN CATHETER-INDUCED THROMBOSIS IN THROMBOCYTOPENIC PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION

      Cancer
    91. CAMPOS L; GUYOTAT D
      BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES BLOCK IN-VITRO PROLIFERATION AND SURVIVAL OF NORMAL MARROW PROGENITORS AND MYELOID-LEUKEMIA CELLS

      Blood
    92. PIGNON B; HAROUSSEAU JL; WITZ F; DESABLENS B; LEPRISE PY; BOASSON M; LINASSIER C; ABGRALL JF; SOLARY E; LIOURE B; CAHN JY; CASASSUS P; SADDOUN A; AUDHUY B; GUYOTAT D; BRIERE J; VILQUE JP; DANEL P; BERTHAUD P
      INDUCTION THERAPY FOLLOWED BY A UNIQUE INTENSIVE CONSOLIDATION COURSEIN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AGED 50 TO 65 - RESULTS OF THE GOELAM GROUP

      Blood
    93. THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D; ARCHIMBAUD E
      PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION (BMT) IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA (AML)

      Blood
    94. CAMPOS L; ROUAULT JP; SABIDO O; ORIOL P; ROUBI N; VASSELON C; ARCHIMBAUD E; MAGAUD JP; GUYOTAT D
      HIGH EXPRESSION OF BCL-2 PROTEIN IN ACUTE MYELOID-LEUKEMIA CELLS IS ASSOCIATED WITH POOR RESPONSE TO CHEMOTHERAPY

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 15:25:21